Stay updated with breaking news from Ikena oncology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Ikena Oncology, Inc. (NASDAQ:IKNA – Get Free Report) was the target of a large drop in short interest in May. As of May 15th, there was short interest totalling 1,380,000 shares, a drop of 9.2% from the April 30th total of 1,520,000 shares. Approximately 5.9% of the company’s stock are sold short. Based on an […] ....
Wedbush cut shares of Ikena Oncology (NASDAQ:IKNA – Free Report) from an outperform rating to a neutral rating in a research note issued to investors on Wednesday, Marketbeat Ratings reports. The firm currently has $2.00 price target on the stock, down from their prior price target of $8.00. Wedbush also issued estimates for Ikena Oncology’s […] ....
Ikena Oncology (NASDAQ:IKNA – Free Report) had its target price cut by HC Wainwright from $11.00 to $4.00 in a research note published on Wednesday morning, Benzinga reports. They currently have a buy rating on the stock. HC Wainwright also issued estimates for Ikena Oncology’s Q2 2024 earnings at ($0.29) EPS, Q3 2024 earnings at […] ....
Wedbush downgraded shares of Ikena Oncology (NASDAQ:IKNA – Free Report) from an outperform rating to a neutral rating in a research report sent to investors on Wednesday morning, MarketBeat reports. The brokerage currently has $2.00 target price on the stock, down from their previous target price of $8.00. Wedbush also issued estimates for Ikena Oncology’s […] ....